<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prescription Drug User Fee Act of 2023 VII Meetings Program for Model-Informed Drug Development Approaches</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prescription Drug User Fee Act of 2023 VII Meetings Program for Model-Informed Drug Development Approaches</h1>
    <p class="timestamp">Published: 2023-01-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The seventh iteration of the Prescription Drug User Fee Act (PDUFA VII), incorporated as part of the FDA User Fee Reauthorization Act of 2022, highlights the goal of advancing model-informed drug development (MIDD). The Food and Drug Administration (FDA or Agency) is announcing the continuation of the MIDD Paired Meeting Program that affords sponsors who are selected for participation the opportunity to meet with Agency staff to discuss MIDD approaches in medical product development. Meetings un...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-00389</p>
    <p><strong>Publication Date:</strong> 2023-01-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/01/11/2023-00389/prescription-drug-user-fee-act-of-2023-vii-meetings-program-for-model-informed-drug-development">https://www.federalregister.gov/documents/2023/01/11/2023-00389/prescription-drug-user-fee-act-of-2023-vii-meetings-program-for-model-informed-drug-development</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-00389</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
